Creative One Wealth, LLC Repligen Corp Transaction History

Creative One Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $51,494 - $82,243	-321 Reduced 12.12%	2,327 $435,000
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $8,722 - $11,657	62 Added 2.4%	2,648 $430,000
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $42,876 - $68,617	266 Added 11.47%	2,586 $486,000
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $14,855 - $18,268	60 Added 2.65%	2,320 $614,000
Q3 2021 Nov 16, 2021	BUY	$194.77 - $324.21 $7,790 - $12,968	40 Added 1.8%	2,260 $653,000
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $368,231 - $490,509	2,220 New	2,220 $443,000
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $304,464 - $381,926	-1,688 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $249,959 - $348,690	1,688 New	1,688 $323,000

486

56.5M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.